Outcomes of TP53-mutated AML with evolving frontline therapies: Impact of allogeneic stem cell transplantation on survival.

Outcomes of TP53-mutated AML with evolving frontline therapies: Impact of allogeneic stem cell transplantation on survival. Am J Hematol. 2022 07; 97(7):E232-E235.

View in: PubMed

subject areas

Hematopoietic Stem Cell Transplantation
Humans
Leukemia, Myeloid, Acute
Tumor Suppressor Protein p53

authors with profiles

Anand Patel
Adam DuVall